JMV 390-1

JMV 390-1 is a synthetic peptide compound designed for advanced biochemical and pharmacological research. As a member of the neuropeptide Y (NPY) receptor ligand family, it is structurally engineered to interact with specific NPY receptor subtypes, enabling precise modulation of receptor-mediated signaling pathways. Its well-characterized sequence and receptor selectivity make it a valuable molecular tool for dissecting the roles of NPY receptors in diverse physiological and cellular processes. The compound's unique properties have established it as a key reagent for in vitro and in vivo studies focused on neuropeptidergic signaling, receptor pharmacology, and peptide-receptor interactions.

Receptor Binding Studies: JMV 390-1 is widely employed in receptor binding assays to elucidate the affinity and selectivity profiles of NPY receptor subtypes. By serving as a reference ligand or competitive antagonist, it allows researchers to map receptor-ligand interactions and quantify binding parameters, such as dissociation constants and receptor density. These studies are essential for understanding receptor pharmacodynamics and for the development of new ligands with improved specificity or efficacy.

Signal Transduction Research: The compound is instrumental in investigating intracellular signaling cascades triggered by NPY receptor activation. Through its ability to selectively modulate receptor activity, JMV 390-1 facilitates the dissection of downstream events such as G-protein coupling, second messenger generation, and kinase activation. These mechanistic insights are critical for unraveling the complex signaling networks that govern cellular responses to neuropeptides.

Functional Characterization of Receptor Subtypes: JMV 390-1 supports the functional analysis of individual NPY receptor subtypes in heterologous expression systems or native tissues. By acting as an agonist or antagonist, depending on the experimental context, it enables researchers to delineate the physiological roles of specific receptors in processes like neurotransmitter release, hormone secretion, and synaptic plasticity. Such studies provide a foundation for understanding the broader biological significance of the NPY signaling axis.

Peptide Structure-Activity Relationship Analysis: As a structurally defined peptide ligand, JMV 390-1 is a valuable reference for structure-activity relationship (SAR) investigations. Researchers utilize it to compare the functional consequences of sequence modifications, assess the impact of amino acid substitutions, and guide the rational design of novel peptide analogs. SAR studies leveraging this compound contribute to the optimization of ligand-receptor interactions and the creation of next-generation modulators with tailored properties.

In vivo Behavioral and Physiological Models: Although not intended for clinical use, JMV 390-1 is frequently incorporated into animal model studies to probe the physiological and behavioral effects of NPY receptor modulation. By administering the compound in controlled experimental settings, researchers can assess its influence on endpoints such as feeding behavior, stress response, and metabolic regulation. These applications help clarify the in vivo relevance of peptide-receptor signaling and support the translation of basic findings into broader biological contexts.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction